Stool Testing for Colorectal Cancer Screening

Gastroenterology

Volumn 149, Issue 5, 2015, Pages 1286-1293

  Robertson, Douglas J ^a   Imperiale, Thomas F ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c REGENSTRIEF INSTITUTE   (United States)

Author keywords

Biomarkers; Colorectal Cancer Screening; Fecal Immunochemical Test; Stool DNA

Indexed keywords

APC PROTEIN; CALGRANULIN; CALGRANULIN B; CLUSTERIN; HEMOGLOBIN; K RAS PROTEIN; LACTOFERRIN; M2 PYRUVATE KINASE; MICRORNA; MICRORNA 106A; MICRORNA 135B; MICRORNA 143; MICRORNA 21; MICRORNA 29B; MICRORNA 9; MICRORNA 92A; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOGENIN; TUMOR MARKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; FECES ANALYSIS; HUMAN; IMMUNOCHEMISTRY; OCCULT BLOOD TEST; PRIORITY JOURNAL; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FECES; MASS SCREENING; METABOLISM; PROCEDURES;

BIOMARKERS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING;

EID: 84943255921     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.05.045     Document Type: Article

References (58)

1. N. Saquib, J. Saquib, and J.P. Ioannidis Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials Int J Epidemiol 44 2015 264 277
2. P. Hewitson, P. Glasziou, E. Watson, and et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update Am J Gastroenterol 103 2008 1541 1549
3. W.S. Atkin, R. Edwards, I. Kralj-Hans, and et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 2010 1624 1633
4. R.E. Schoen, P.F. Pinsky, J.L. Weissfeld, and et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy N Engl J Med 366 2012 2345 2357
5. S.J. Winawer, A.G. Zauber, M.N. Ho, and et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1993 1977 1981
6. R. Nishihara, K. Wu, P. Lochhead, and et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy N Engl J Med 369 2013 1095 1105
7. K. Garborg, ∅. Holme, M. Løberg, and et al. Current status of screening for colorectal cancer Ann Oncol 24 2013 1963 1972
8. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 627 637
9. Vital signs: colorectal cancer screening test use - United States, 2012 MMWR Morb Mortal Wkly Rep 62 2013 881 888
10. J.K. Lee, T.R. Levin, and D.A. Corley The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol 11 2013 204 207
11. H.G. Welch, and W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605 613
12. K.M. Kuntz, I. Lansdorp-Vogelaar, C.M. Rutter, and et al. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression Med Decis Making 31 2011 530 539
13. P.C. Schroy 3rd, S. Lal, J.T. Glick, and et al. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care 13 2007 393 400
14. J.M. Inadomi, S. Vijan, N.K. Janz, and et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies Archives of internal medicine 172 2012 575 582
15. A. Shaukat, S.J. Mongin, M.S. Geisser, and et al. Long-term mortality after screening for colorectal cancer N Engl J Med 369 2013 1106 1114
16. D. Heresbach, S. Manfredi, P.N. D'Halluin, and et al. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test Eur J Gastroenterol Hepatol 18 2006 427 433
17. US Preventive Services Task Force Screening for colorectal cancer: US Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 627 637
18. D.A. Ahlquist, D.J. Sargent, C.L. Loprinzi, and et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann Intern Med 149 2008 441 450
19. T.F. Imperiale, D.F. Ransohoff, S.H. Itzkowitz, and et al. Multitarget stool DNA testing for colorectal-cancer screening N Engl J Med 370 2014 1287 1297
20. T.F. Imperiale, D.F. Ransohoff, S.H. Itzkowitz, and et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 351 2004 2704 2714
21. J.K. Lee, E.G. Liles, S. Bent, and et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis Ann Intern Med 160 2014 171
22. S. Hundt, U. Haug, and H. Brenner Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection Ann Intern Med 150 2009 162 169
23. S. Crotta, N. Segnan, S. Paganin, and et al. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test Clin Gastroenterol Hepatol 10 2012 633 638
24. M.J. Denters, M. Deutekom, P.M. Bossuyt, and et al. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer Gastroenterology 142 2012 497 504
25. A. Kapidzic, E.J. Grobbee, L. Hol, and et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening Am J Gastroenterol 109 2014 1257 1264
26. B.T. Levy, C. Bay, Y. Xu, and et al. Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy J Med Screen 21 2014 133 143
27. C.G. Fraser, J.E. Allison, G.P. Young, and et al. Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening Clin Gastroenterol Hepatol 11 2013 839 840
28. P.J. McDonald, J.A. Strachan, J. Digby, and et al. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer Clin Chem Lab Med 50 2012 935 940
29. C.G. Fraser, J.E. Allison, S.P. Halloran, and et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin J Natl Cancer Inst 104 2012 810 814
30. J.A. Wilschut, L. Hol, E. Dekker, and et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening Gastroenterology 141 2011 1648 1655.e1
31. J.M. Auge, M. Pellise, J.M. Escudero, and et al. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program Gastroenterology 147 2014 628 636.e1
32. E. Quintero, A. Castells, L. Bujanda, and et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening N Engl J Med 366 2012 697 706
33. Clinical Trials. CONFRIM trial. Available at: http://www.clinicaltrials.gov/ct2/show/NCT01239082. Accessed March 16, 2015.
34. T.H. Chiang, S.L. Chuang, S.L. Chen, and et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program Gastroenterology 147 2014 1317 1326
35. E. Quintero, M. Carrillo, A.Z. Gimeno-Garcia, and et al. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening Gastroenterology 147 2014 1021 1030 e1 quiz e16-17
36. J.M. Lane, E. Chow, G.P. Young, and et al. Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia Gastroenterology 139 2010 1918 1926
37. K.A. Boynton, I.C. Summerhayes, D.A. Ahlquist, and et al. DNA integrity as a potential marker for stool-based detection of colorectal cancer Clin Chem 49 2003 1058 1065
38. B. Levin, D.A. Lieberman, B. McFarland, and et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
39. D.K. Rex, D.A. Johnson, J.C. Anderson, and et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am J Gastroenterol 104 2009 739 750
40. D.A. Ahlquist, H. Zou, M. Domanico, and et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas Gastroenterology 142 2012 248 256 quiz e25-26
41. G. Hoff, T. Grotmol, E. Thiis-Evensen, and et al. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT) Gut 53 2004 1329 1333
42. B.C. Yoo, Y.K. Shin, S.B. Lim, and et al. Evaluation of calgranulin B in stools from the patients with colorectal cancer Dis Colon Rectum 51 2008 1703 1709
43. R. Li, J. Liu, H. Xue, and et al. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis Int J Cancer 131 2012 1837 1845
44. R. Leen, C. Seng-Lee, G. Holleran, and et al. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort Eur J Gastroenterol Hepatol 26 2014 514 518
45. N.C. Verberkmoes, A.L. Russell, M. Shah, and et al. Shotgun metaproteomics of the human distal gut microbiota ISME J 3 2009 179 189
46. J. Karl, N. Wild, M. Tacke, and et al. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers Clin Gastroenterol Hepatol 6 2008 1122 1128
47. H.P. Wang, Y.Y. Wang, J. Pan, and et al. Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer World J Gastroenterol 20 2014 1332 1339
48. S. Hrasovec, and D. Glavac MicroRNAs as novel biomarkers in colorectal cancer Front Genet 3 2012 180
49. A. Ren, Y. Dong, H. Tsoi, and et al. Detection of mi-RNA as non-invasive biomarkers of colorectal cancer Int J Mol Sci 16 2015 2810 2823
50. Y. Ma, P. Zhang, J. Yang, and et al. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation Int J Cancer 130 2012 2077 2087
51. F.E. Ahmed, N.C. Ahmed, P.W. Vos, and et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool. I. Proof of principle Cancer Genom Proteom 10 2013 93 113
52. S.J. Heitman, R.J. Hilsden, F. Au, and et al. Colorectal cancer screening for average-risk North Americans: an economic evaluation PLoS Med 7 2010 e1000370
53. I. Lansdorp-Vogelaar, M. van Ballegooijen, A.G. Zauber, and et al. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening J Natl Cancer Inst 101 2009 1412 1422
54. M. Parekh, A.M. Fendrick, and U. Ladabaum As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia Aliment Pharmacol Ther 27 2008 697 712
55. L.G. van Rossum, A.F. van Rijn, A.L. Verbeek, and et al. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis Int J Cancer 128 2011 1908 1917
56. A.G. Zauber, I. Lansdorp-Vogelaar, A.B. Knudsen, and et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force Ann Intern Med 149 2008 659 669
57. I. Lansdorp-Vogelaar, K.M. Kuntz, A.B. Knudsen, and et al. Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis Ann Intern Med 153 2010 368 377
58. D.A. Lieberman, D.K. Rex, S.J. Winawer, and et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 143 2012 844 857